Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diagnostic Test Kits for Dengue Virus Detection Evaluated

By LabMedica International staff writers
Posted on 28 Oct 2014
Laboratory diagnosis of dengue with a single serum specimen obtained during the acute phase of the illness requires tests to detect immunoglobulin M (IgM) antibodies to Dengue virus or the virus genome.

Commercially available diagnostic test kits for detection of the Dengue virus (DENV) non-structural protein 1 (NS1) and anti-DENV IgM have been evaluated for their sensitivity and specificity and other performance characteristics. More...


An international team of scientists led by those at the [US] Centers for Disease Control and Prevention (CDC; San Juan, Puerto Rico) examined newly available commercial tests that detect the virus protein NS1, as well as new tests for IgM anti-DENV in microplate or rapid diagnostic test (RDT) formats. This analytic study used specimens from laboratory confirmed dengue patients worldwide, which makes the results widely generalizable.

A DENV NS1 panel cconsisted of a total of 390 dengue patient serum specimens in three sub-panels: 192 dengue patients who were DENV positive by virus isolation and/or polymerase chain reaction (PCR) for DENV ribonucleic acid (RNA), 146 DENV RNA or culture negatives, and 52 challenge specimens from other illnesses or conditions. An anti-DENV IgM panel consisted of three subpanels with 527 patient serum specimens: 228 anti-DENV IgM positive paired specimens from patients with dengue and 155 DENV IgM negative and 144 challenge specimens. All specimens were tested by the solid-phase anti-DENV IgM Antibody Capture Enzyme Linked Immunosorbent Assay (IgM MAC-ELISA).

The DENV kits from seven different manufacturers were tested. The results were analyzed to determine sensitivity, specificity, inter-laboratory and inter-reader agreement, lot-to-lot variation and ease-of-use. NS1 ELISA sensitivity was 60% to 75% and specificity 71% to 80%; NS1 RDT sensitivity was 38% to 71% and specificity 76% to 80%; the IgM anti-DENV RDTs sensitivity was 30% to 96%, with a specificity of 86% to 92%, and IgM anti-DENV ELISA sensitivity was 96% to 98% and specificity 78% to 91%.

The authors concluded that NS1 tests were generally more sensitive in specimens from the acute phase of dengue and in primary DENV infection, whereas IgM anti-DENV tests were less sensitive in secondary DENV infections. The reproducibility of the NS1 RDTs ranged from 92% to 99% and the IgM anti-DENV RDTs from 88% to 94%.The study was published on October 16, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Centers for Disease Control and Prevention 



New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.